Nanexa AB Shares Surge 7.8% as Investors Eye Nanotechnology Breakthroughs

Nanexa AB (ticker NANEXA) is on a rally, with its shares up 1.64 % in the last 24 hours to 12.16 SEK. The Swedish nanotechnology firm has seen a 7.82 % jump in intraday trading, a 6.27 % rise over five days, and a 24.84 % increase over the past month. Year‑to‑date performance stands at 33.41 %, while the last twelve months have delivered a staggering 163.56 % gain. Over the past six months the stock has climbed 63.14 %, but a ten‑year decline of 23.39 % remains a cautionary backdrop.

Founded in 2007 by Mats Boman, Jan‑Otto Carlsson, Christian Östberg, Anders Hårsta, Mårten Rooth, Jessica Östberg and Anders Johansson, Nanexa develops, produces and distributes medical nanotechnology solutions. Its flagship product, PharmaShell, offers new routes for drug administration, precise dosing and targeted delivery of parenteral therapies. The company also markets a gas‑barrier and antifungal coating that protects medical devices.

Nanexa’s market capitalization is 905.22 million SEK, up 5.95 % in the last week. The firm’s all‑time high was 14.34 SEK on 18 December 2020, while the lowest recorded price was 0.60 SEK on 17 April 2024. With a volatility of 78.96 % and a beta of –0.24, the stock is considered highly volatile and slightly counter‑cyclical.

Financially, the most recent quarter reported a net loss of 14.03 million SEK, unchanged from the prior quarter’s 14.02 million SEK loss. EBITDA was –9.22 million SEK, giving an EBITDA margin of –26.49 %. Nanexa does not pay dividends.

The company has 15 employees and is headquartered in Uppsala, Sweden. Its next earnings announcement is scheduled for 5 November 2026. Investors are watching the firm’s progress in nanotechnology applications as a potential catalyst for further upside.